A Novel Spirocyclic Dimer (SpiD3) Resensitizes CLL Cells to Venetoclax
Year: 2022
Type: article
Source: Blood
Institution: University of Nebraska Medical Center
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4310106537
